Bone marrow angiogenesis has been reported to increase in several hematologic malignant diseases, including multiple myeloma. Because high-dose chemotherapy combined with autologous stem cell transplantation (SCT) improves the response rate, event-free survival, and overall survival in patients with multiple myeloma (MM), we studied the changes in bone marrow microvessel density (MVD) in 21 patients who underwent high-dose chemotherapy combined with autologous SCT to determine whether there was persistently increased angiogenesis at the time of response. Bone marrow biopsy specimens were obtained before and after SCT for each patient and immunostained with anti-CD34 antibodies for the identification of microvascular endothelial cells. The mean value of MVD in 21 MM patients at initial diagnosis was 46.0 ± 24.0 and in healthy controls was 26.8 ± 8.54 (P = .046). The mean MVD at initial diagnosis was 46.0 ± 24.0 compared with 29.0 ± 12.5 after achievement of response with SCT, and there was a statistically significant difference (P = .004). Sixteen of 21 patients (76.2%) had decreased MVD after SCT, and 5 patients were found to have a greater than 50% decrease in MVD after SCT. However, there was no difference in overall survival between the patient group with decreased MVD after SCT and that without decreased MVDP = .9370). These results suggest that angiogenesis plays an important role in MM. In addition, the persistence of MVD at the time of response indicates continuous stimulus of microvessels by minimal residual disease even after SCT. Int J Hematol. 2002;76:465-470.
This is a preview of subscription content, log in to check access.
Buy single article
Instant access to the full article PDF.
Price includes VAT for USA
Subscribe to journal
Immediate online access to all issues from 2019. Subscription will auto renew annually.
This is the net price. Taxes to be calculated in checkout.
Weidner N, Semple HP, Welch WR, Folkman J.Tumor angiogenesis and metastasis-correlation in invasive breast carcinoma.N Engl J Med. 1991;324:1–8.
Dickinson AH, Fow SB, Persad RA, Hollyer J, Sibley GN, Harris AL. Quantification of angiogenesis as an independent predictor of prognosis in invasive bladder carcinomas.Br J Urol. 1994;74: 762–766.
Folkman J. Seminars in medicine of the Beth Israel Hospital, Boston: clinical applications of research on angiogenesis.N Engl J Med. 1995;333:1757–1763.
Folkman J. New perspectives in clinical oncology from angiogenesis research.Eur J Cancer. 1996;32A:2534–2539.
Fox SB. Tumor angiogenesis and prognosis.Histopathology. 1997; 30:294–301.
Hamada J, Cavanaugh PG, Lotan O, Nicholoson G. Separable growth and migration factors for large-cell lymphoma cells secreted by microvascular endothelial cells derived from target organs for metastasis.Br J Cancer. 1992;66:349–354.
Rank J, Filmus J, Kerbel RS. Reciprocal paracrine interactions between tumor cells and endothelial cells: the angiogenesis progression hypothesis.Eur J Cancer. 1996;32A:2438–2450.
Gasparini G, Weidner N, Maluta S, et al. Intratumoral microvessel density and p53 protein: correlation with metastasis in head and neck squamous cell carcinoma.Int J Cancer. 1993;55:739–744.
Ellis LM, Fidler IJ. Angiogenesis and breast cancer metastasis.Lancet. 1995;346:388–390.
Maeda K, Chung YS, Takasuka S, et al. Tumor angiogenesis as a predictor of recurrence in gastric carcinoma.J Clin Oncol. 1995;13: 477–481.
Wiggins DL, Granai CO, Steinhoff MM, Calabresi P. Tumor angio- genesis as a prognostic factor in cervical carcinoma.Gynecol Oncol. 1995;56:353–356.
Fontanini G, Lucchi M, Vignati S, et al. Angiogenesis as a prognostic indicator of survival in non-small cell lung carcinoma: a prospective study.J Natl Cancer Inst. 1997:89:881–886.
Acenero MJ, Gonzalex JF, Gallego MG, Ballesteros PA. Vascular enumeration as a significant prognosticator for invasive breast carcinoma.J Clin Oncol. 1998;16:1684–1689.
Vacca A, Ribatti D, Roncali L, Dammacco F. Angiogenesis in B cell lymphoproliferative diseases: biological and clinical studies.Leuk Lymphoma. 1995;20:27–38.
Perez-Atayde AR, Sallan SE, Tedrow U, Connors EA, Folkman J. Spectrum of tumor angiogenesis in the bone marrow of children with acute lymphoblastic leukemia.Am J Pathol. 1997;150:815–821.
Padro T, Ruiz S, Bieker R, et al. Increased angiogenesis in the bone marrow of patients with acute myeloid leukemia.Blood. 2000;95: 2637–2644.
Vacca A, Ribatti D, Roncali L, et al. Bone marrow angiogenesis and progression in multiple myeloma.Br J Haematol. 1994;87: 503–508.
Barlogie B, Epstein J, Selvanayagam P. Plasma cell myeloma: new insights and advances in therapy.Blood. 1989;73:865–879.
Attal M, Harousseau JL, Stoppa AM, et al. A prospective randomized trial of autologous bone marrow transplantation and chemotherapy in multiple myeloma. Intergroupe Francais du Myelome.N Engl J Med. 1996;335:91–97.
Durie BGM, Salmon SE. Multiple myeloma, macroglobulinemia, and monoclonal gammopathies. In: Hoffbrand AB, Brain MC, Hirsh J, eds.Recent Advances in Hematology. New York, NY: Churchill Livingstone; 1977:243–261.
Vermeulen PB, Gasparini G, Fox SB, et al. Quantification of angio- genesis in solid human tumors: an international consensus on the methodology and criteria of evaluation.Eur J Cancer. 1996;32A: 2474–2484.
Dankbar B, Padro T, Leo R, et al. Vascular endothelial growth factor and interleukin-6 in paracrine tumor-stromal cell interactions in multiple myeloma.Blood. 2000;95:2630–2636.
Rajkumar SB, Fonseca R, Witzig TE, Gertx MA, Geipp PR. Bone marrow angiogenesis in patients achieving complete response after stem cell transplantation for multiple myeloma.Leukemia. 1999; 13:469–472.
Barille A, Akhoundi C, Collette M, et al. Metalloproteinases in multiple myeloma: production of matrix metalloproteinase-9, activation of proMMP-2, and induction of MMP-1 by myeloma cells.Blood. 1997;90:1649–1655.
Vacca A, Ribatti D, Presta M, et al. Bone marrow neovascularization, plasma cell angiogenic potential, and matrix metalloproteinase-2 secretion parallel progression of human multiple myeloma.Blood. 1999;93:3064–3073.
About this article
Cite this article
Oh, H.S., Choi, J., Park, C.K. et al. Comparison of Microvessel Density Before and after Peripheral Blood Stem Cell Transplantation in Multiple Myeloma Patients and Its Clinical Implications: Multicenter Trial. Int J Hematol 76, 465–470 (2002). https://doi.org/10.1007/BF02982813
- Microvessel density
- Multiple myeloma
- Stem cell transplantation